▲ Peaking
Business
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Novartis has entered into an agreement to acquire UK-based biotechnology firm Myricx Bio in a deal valued at up to $1.5 billion.
1 trends tracked about this subject — the full history, oldest to newest below.
Novartis has entered into an agreement to acquire UK-based biotechnology firm Myricx Bio in a deal valued at up to $1.5 billion.